GC3111B

· GC Biopharma Corp

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GC3111B, covering 2025-07-10 to 2025-07-10. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults [Phase 1, Phase 2]